Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
Adolescents
Risk group
Clear all
Type of publications
NITAG documentation
(13)
SAGE documentation
(2)
Systematic reviews (SYSVAC)
(490)
Topics
Agenda & Minutes
(2)
Background paper
(2)
Recommendation
(9)
Regions
Africa
(1)
Americas
(7)
Europe
(5)
Countries
Belgium
(2)
Canada
(1)
Chile
(1)
France
(1)
Luxembourg
(1)
Uganda
(1)
United Kingdom
(1)
United States of America
(5)
Diseases
COVID-19
(7)
Hepatitis A
(1)
Herpes zoster
(2)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Japanese encephalitis
(2)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Publication date
2023
(1)
2022
(5)
2021
(2)
2020
(3)
2018
(1)
2017
(1)
Target population
Adolescents
(6)
Risk group
(7)
Adults
(8)
All age groups
(1)
Children
(22)
Healthcare workers
(4)
Migrants
(1)
Newborn
(8)
Older adults
(10)
Pregnant women
(8)
Available to download in languages
English (EN)
(7)
French (FR)
(4)
Spanish (ES)
(1)
13 results found
2023
∙
Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
2022
∙
Conseil Supérieur des Maladies Infectieuses
Recommendations for the shingles vaccination
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
UNITAG
Advisory on Ministry of Health proposal to vaccinate persons 5-17 years of age against COVID-19 in Uganda
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2021
∙
JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
ACIP
COVID-19 vaccine prioritization: Work Group considerations
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register